HYOU1
Hypoxia up-regulated protein 1
Also known as: Grp170, HSP12A, HYOU1_HUMAN, ORP150
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y4L1
- Gene
- HYOU1
- Ensembl
- ENSG00000149428
- Chromosome
- 11
- Canonical length
- 999 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene belongs to the heat shock protein 70 family. This gene uses alternative transcription start sites. A cis-acting segment found in the 5' UTR is involved in stress-dependent induction, resulting in the accumulation of this protein in the endoplasmic reticulum (ER) under hypoxic conditions. The protein encoded by this gene is thought to play an important role in protein folding and secretion in the ER. Since suppression of the protein is associated with accelerated apoptosis, it is also suggested to have an important cytoprotective role in hypoxia-induced cellular perturbation. This protein has been shown to be up-regulated in tumors, especially in breast tumors, and thus it is associated with tumor invasiveness. This gene also has an alternative translation initiation site, resulting in a protein that lacks the N-terminal signal peptide. This signal peptide-lacking protein, which is only 3 amino acids shorter than the mature protein in the ER, is thought to have a housekeeping function in the cytosol. In rat, this protein localizes to both the ER by a carboxy-terminal peptide sequence and to mitochondria by an amino-terminal targeting signal. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Canonical amino-acid sequenceUniProt
999 residues, UniProt reviewed canonical sequence.
>Q9Y4L1|HYOU1
1 MADKVRRQRP RRRVCWALVA VLLADLLALS DTLAVMSVDL GSESMKVAIV KPGVPMEIVL
61 NKESRRKTPV IVTLKENERF FGDSAASMAI KNPKATLRYF QHLLGKQADN PHVALYQARF
121 PEHELTFDPQ RQTVHFQISS QLQFSPEEVL GMVLNYSRSL AEDFAEQPIK DAVITVPVFF
181 NQAERRAVLQ AARMAGLKVL QLINDNTATA LSYGVFRRKD INTTAQNIMF YDMGSGSTVC
241 TIVTYQMVKT KEAGMQPQLQ IRGVGFDRTL GGLEMELRLR ERLAGLFNEQ RKGQRAKDVR
301 ENPRAMAKLL REANRLKTVL SANADHMAQI EGLMDDVDFK AKVTRVEFEE LCADLFERVP
361 GPVQQALQSA EMSLDEIEQV ILVGGATRVP RVQEVLLKAV GKEELGKNIN ADEAAAMGAV
421 YQAAALSKAF KVKPFVVRDA VVYPILVEFT REVEEEPGIH SLKHNKRVLF SRMGPYPQRK
481 VITFNRYSHD FNFHINYGDL GFLGPEDLRV FGSQNLTTVK LKGVGDSFKK YPDYESKGIK
541 AHFNLDESGV LSLDRVESVF ETLVEDSAEE ESTLTKLGNT ISSLFGGGTT PDAKENGTDT
601 VQEEEESPAE GSKDEPGEQV ELKEEAEAPV EDGSQPPPPE PKGDATPEGE KATEKENGDK
661 SEAQKPSEKA EAGPEGVAPA PEGEKKQKPA RKRRMVEEIG VELVVLDLPD LPEDKLAQSV
721 QKLQDLTLRD LEKQEREKAA NSLEAFIFET QDKLYQPEYQ EVSTEEQREE ISGKLSAAST
781 WLEDEGVGAT TVMLKEKLAE LRKLCQGLFF RVEERKKWPE RLSALDNLLN HSSMFLKGAR
841 LIPEMDQIFT EVEMTTLEKV INETWAWKNA TLAEQAKLPA TEKPVLLSKD IEAKMMALDR
901 EVQYLLNKAK FTKPRPRPKD KNGTRAEPPL NASASDQGEK VIPPAGQTED AEPISEPEKV
961 ETGSEPGDTE PLELGGPGAE PEQKEQSTGQ KRPLKNDELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HYOU1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 105 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 105 nTPM
- liver: 103 nTPM
- epididymis: 103 nTPM
- thyroid gland: 92 nTPM
- testis: 59 nTPM
- pituitary gland: 55 nTPM
Single-cell type
- plasma cells: 37 nCPM
- corticotrophs: 36 nCPM
- early spermatids: 35 nCPM
- other brain neurons: 30 nCPM
- late spermatids: 30 nCPM
- brain inhibitory neurons: 21 nCPM
Immune cell
- plasmacytoid DC: 16 nTPM
- MAIT T-cell: 8.7 nTPM
- gdT-cell: 8 nTPM
- memory CD8 T-cell: 6.1 nTPM
- total PBMC: 4.9 nTPM
- intermediate monocyte: 4.8 nTPM
Brain region
- hypothalamus: 91 nTPM
- thalamus: 75 nTPM
- midbrain: 72 nTPM
- pons: 71 nTPM
- white matter: 69 nTPM
- medulla oblongata: 67 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HYOU1.
Disease | AllUniProt
Conditions HYOU1 is implicated in, by any mechanism.
- Immunodeficiency 59 and hypoglycemia (IMD59) MIM:233600
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 867 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Granulocytopenia with immunoglobulin abnormality
ReferencesPubMed · IEDB
Publications for HYOU1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- 150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoprotein.
1996 · J Clin Invest · RCR 1.3 · 73 citations - Increased stress protein ORP150 autoantibody production in Type 1 diabetic patients.
2006 · Diabet Med · RCR 0.4 · 18 citations - The increment of anti-ORP150 autoantibody in initial stages of atheroma in high-fat diet fed mice.
2002 · J Vet Med Sci · RCR 0.2 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.86
- gnomAD missense Z
- 1.8
- DepMap mean gene effect
- -1.04
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hypoxia
- endoplasmic reticulum to Golgi vesicle-mediated transport
- negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway
- negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway
- response to endoplasmic reticulum stress
- response to ischemia
Molecular functions
- adenyl-nucleotide exchange factor activity
- ATP binding
- ATP-dependent protein folding chaperone
- protein-folding chaperone binding
- unfolded protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HYOU1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HYOU1 as an antibody target. Whether an autoantibody or antibody against HYOU1 could matter depends on whether native HYOU1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HYOU1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HYOU1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...